Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.38B P/E - EPS this Y -29.40% Ern Qtrly Grth -
Income -184.68M Forward P/E -10.26 EPS next Y 50.00% 50D Avg Chg 39.00%
Sales 77.43M PEG 1.07 EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 7.59 EPS next 5Y -9.00% 52W High Chg -30.00%
Recommedations 1.70 Quick Ratio 5.27 Shares Outstanding 60.97M 52W Low Chg 57.00%
Insider Own 0.54% ROA -32.22% Shares Float 44.98M Beta 1.93
Inst Own 112.56% ROE -85.10% Shares Shorted/Prior 10.20M/9.20M Price 24.32
Gross Margin 87.99% Profit Margin -238.52% Avg. Volume 772,256 Target Price 59.00
Oper. Margin -170.28% Earnings Date May 7 Volume 3,218,385 Change 6.90%
About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Rhythm Pharmaceuticals, Inc. News
05/01/24 Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
04/30/24 Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline
04/29/24 Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
04/24/24 Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
04/16/24 Rhythm Pharmaceuticals Announces New Employment Inducement Grants
04/14/24 Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
04/10/24 Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
04/01/24 Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
03/25/24 Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
03/22/24 Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)
03/20/24 Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares
03/20/24 Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...
03/20/24 Insider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM)
03/06/24 Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
03/03/24 Rhythm Pharmaceuticals Full Year 2023 Earnings: Revenues Disappoint
02/24/24 Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
02/23/24 Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript
02/22/24 Q4 2023 Rhythm Pharmaceuticals Inc Earnings Call
02/22/24 Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Misses Revenue Estimates
02/22/24 Rhythm Pharmaceuticals Inc (RYTM) Reports Q4 and Full Year 2023 Financial Results
RYTM Chatroom

User Image Doozio Posted - 16 hours ago

If $xbi starts leading da 🧠 will get in $rytm wit da huckleberries while da XLE 🐑 will start $dyn in 🧠⏰. Barring a faatch 💣

User Image History101 Posted - 04/30/24

$RYTM I added today. CNBC article on April 10th is bullish on RYTM: https://www.cnbc.com/2024/04/10/biotech-stocks-are-ready-to-break-out-they-just-need-one-more-thing.html

User Image MaverikIT Posted - 04/30/24

@net0trader @IsabellaDC @Im_not_Mr_Lebowski @DonCorleone77 @RonIsWrong @Cash4freedom @Wigglyick Ron, $RYTM

User Image Stock_Titan Posted - 04/29/24

$RYTM Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology https://www.stocktitan.net/news/RYTM/rhythm-pharmaceuticals-announces-publication-of-results-from-phase-2-dqt935pegvwo.html

User Image Squeezebox Posted - 04/25/24

$RYTM loading up more if drops to 32ish

User Image Stock_Titan Posted - 04/24/24

$RYTM Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 https://www.stocktitan.net/news/RYTM/rhythm-pharmaceuticals-to-report-first-quarter-2024-financial-nlib5y8o4gbx.html

User Image Squeezebox Posted - 04/23/24

$RYTM gimme 43.50 tomorrow

User Image abcdzepeda Posted - 04/23/24

$RYTM can someone refresh my memory, and remind me about News that was to come out in the first half of 2024.

User Image Squeezebox Posted - 04/21/24

$RYTM make me love u again

User Image Squeezebox Posted - 04/19/24

$RYTM terrible

User Image Squeezebox Posted - 04/19/24

$RYTM lame action

User Image Squeezebox Posted - 04/18/24

$RYTM cant gain any traction lately … maybe last few months its been consolidating

User Image Squeezebox Posted - 04/18/24

$RYTM been a dog lately. very unrytmy

User Image RamenLives Posted - 04/17/24

$RYTM Got a feeling big new will be inbound soon...

User Image BioRich Posted - 04/17/24

$RYTM

User Image Squeezebox Posted - 04/17/24

$RYTM this stock doesnt move anymore its like watching snails race

User Image Stock_Titan Posted - 04/16/24

$RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants https://www.stocktitan.net/news/RYTM/rhythm-pharmaceuticals-announces-new-employment-inducement-sl01soufdetk.html

User Image Squeezebox Posted - 04/16/24

$RYTM predictions on buyout premium? and chance of over 100/share?

User Image Squeezebox Posted - 04/16/24

$RYTM this looks stuck at 40 until buyout

User Image abcdzepeda Posted - 04/10/24

$RYTM does anyone have any input on yesterday‘s fire side chat that the CFO presented at yesterday‘s conference? I don’t know why, but it was not available for us to view or listen to. Perhaps there was another way to listen or view this presentation, and I was not aware of it. This is why I am asking for some info. Ty

User Image xbibackto70s Posted - 04/10/24

$RYTM sell the fing co ass hats

User Image S_Franconi Posted - 04/09/24

$RYTM Is this your time to shine?

User Image History101 Posted - 04/09/24

$SLS $SAVA $MESO $NLST $RYTM Just in case, for a brief second, in a pleasant daydream, you thought that maybe the markets are actually fair for the retailer investor... https://www.zerohedge.com/markets/scandal-rocks-bidens-labor-dept-lying-about-sharing-non-public-inflation-data-secret-group

User Image Squeezebox Posted - 04/08/24

$RYTM seems like this hit a wall lately how long til buyout ? and for how much

User Image RonIsWrong Posted - 04/07/24

$PHAT $RYTM $PCVX Phathom Pharmaceuticals ($PHAT), Rhythm Pharmaceuticals ($RYTM), and Vaxcyte ($PCVX) are the most likely takeout targets in the pharma space, according to a Needham analyst. The three companies are the most likely to be acquired in Needham's coverage universe, Needham analyst Joseph Stringer wrote in a note on Friday. Needham has a buy rating and $26 price target on Phathom (PHAT), a buy rating and $95 price target on Vaxcyte (PCVX) and a $50 price target and buy rating on Rhythm (RYTM).

User Image OpenOutcrier Posted - 04/05/24

RECAP 4/5 +Pos Comments: $PCVX + Needham $PHAT + Needham $RYTM + Needham RECAP 4/5 -Neg Comments: $PEGY - Northland $ATUS - WFC Live Breaking trading news www.openoutcrier.com

User Image Quantumup Posted - 04/05/24

Needham believes $RYTM $PHAT $PCVX likely to be acquired: Notes M&A's are well above the 8.2 qtrly avg since '18. Thinks M&A will remain above avg for the remainder of '24 and skew more toward mid-stage target cos w/ deal sizes in the $1-3B range and w/ more focus on Oncology/Immunology/Rare Disease. SNY MRK LLY PFE NVS RHHBY REGN TAK BIIB BMY BAYRY

User Image BioRich Posted - 04/04/24

$TRVI upcoming events. $LLY $RYTM news soon hopefully.

User Image RamenLives Posted - 04/04/24

$RYTM All your friends are green... LFG!

User Image HedgeFollow Posted - 04/04/24

Millennium Management, a top rated Hedge Fund, quadrupled their position in $NARI during past 2 weeks. They bought over $70 million worth of shares. Similar big buys also done in $RYTM, $UTZ, $SPR & $EVRI Source: https://hedgefollow.com/hedge-fund-tracker

Analyst Ratings
Needham Buy Apr 26, 24
Wells Fargo Overweight Apr 18, 24
Needham Buy Apr 10, 24
Needham Buy Feb 22, 24
Goldman Sachs Buy Jan 26, 24
Needham Buy Jan 26, 24
Goldman Sachs Buy Jan 25, 24
Needham Buy Jan 4, 24
Morgan Stanley Overweight Dec 19, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Lee Jennifer Kayden EVP, Head of North A.. EVP, Head of North America Feb 01 Sell 45.06 1,492 67,230 3,021 02/05/24
Smith Hunter C Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 45.06 1,616 72,817 75,215 02/05/24
Shulman Joseph Chief Technical Offi.. Chief Technical Officer Feb 01 Sell 45.06 1,324 59,659 2,614 02/05/24
Meeker David P President and CEO President and CEO Feb 01 Sell 45.06 4,361 196,507 121,099 02/05/24
Cramer Pamela J. Chief Human Resource.. Chief Human Resources Officer Feb 01 Sell 45.06 946 42,627 10,122 02/05/24
Shulman Joseph Chief Technical Offi.. Chief Technical Officer Dec 27 Sell 50.01 12,941 647,179 12/29/23
Shulman Joseph Chief Technical Offi.. Chief Technical Officer Dec 27 Option 21.38 9,200 196,696 7,926 12/29/23
Smith Hunter C Chief Financial Offi.. Chief Financial Officer Nov 24 Sell 35.02 10,974 384,309 61,406 11/28/23
Smith Hunter C Chief Financial Offi.. Chief Financial Officer Nov 24 Option 6.88 10,974 75,501 72,380 11/28/23
Lee Jennifer Kayden EVP, Head of North A.. EVP, Head of North America Nov 08 Sell 28.33 9,150 259,219 1,647 11/13/23
Lee Jennifer Kayden EVP, Head of North A.. EVP, Head of North America Nov 08 Option 6.8 9,150 62,220 5,085 11/13/23
Lee Jennifer Kayden EVP, Head of North A.. EVP, Head of North America Nov 03 Sell 28 80 2,240 1,647 11/07/23
Lee Jennifer Kayden EVP, Head of North A.. EVP, Head of North America Nov 03 Option 6.8 80 544 1,727 11/07/23
Lee Jennifer Kayden EVP, Head of North A.. EVP, Head of North America Sep 05 Sell 28.05 6,166 172,956 1,647 09/07/23
Lee Jennifer Kayden EVP, Head of North A.. EVP, Head of North America Sep 05 Option 6.8 4,519 30,729 7,813 09/07/23
Cramer Pamela J. Chief Human Resource.. Chief Human Resources Officer Jul 26 Sell 17.64 930 16,405 8,418 07/28/23
Roberts William T. Chief Accounting Off.. Chief Accounting Officer Mar 29 Sell 17.5 912 15,960 7,872 03/31/23
Shulman Joseph Chief Technical Offi.. Chief Technical Officer Feb 11 Sell 26.87 554 14,886 3,741 02/14/23
Chien Jennifer EVP, Head of North A.. EVP, Head of North America Feb 11 Sell 26.87 635 17,062 4,940 02/14/23
Smith Hunter C Chief Financial Offi.. Chief Financial Officer Feb 11 Sell 26.87 702 18,863 59,406 02/14/23
Cramer Pamela J. Chief Human Resource.. Chief Human Resources Officer Feb 09 Sell 27.51 843 23,191 6,142 02/14/23
Mazabraud Yann EVP, Head of Interna.. EVP, Head of International Feb 09 Sell 27.51 1,563 42,998 2,973 02/14/23
Roberts William T. Chief Accounting Off.. Chief Accounting Officer Feb 09 Sell 27.51 969 26,657 6,284 02/14/23
Shulman Joseph Chief Technical Offi.. Chief Technical Officer Feb 09 Sell 27.51 931 25,612 2,732 02/14/23
Chien Jennifer EVP, Head of North A.. EVP, Head of North America Feb 09 Sell 27.51 1,204 33,122 3,544 02/14/23
Smith Hunter C Chief Financial Offi.. Chief Financial Officer Feb 09 Sell 27.51 1,413 38,872 57,764 02/14/23
Cramer Pamela J. Chief Human Resource.. Chief Human Resources Officer Jul 26 Sell 11.68 901 10,524 2,224 07/28/22
Smith Hunter C Chief Financial Offi.. Chief Financial Officer Jun 30 Sell 4.08 7,547 30,792 57,614 07/06/22
Roberts William T. Chief Accounting Off.. Chief Accounting Officer Mar 29 Sell 11.13 1,023 11,386 1,477 03/31/22
Shulman Joseph Chief Technical Offi.. Chief Technical Officer Feb 11 Sell 6.1 557 3,398 1,006 02/15/22
Smith Hunter C Chief Financial Offi.. Chief Financial Officer Feb 11 Sell 6.1 833 5,081 40,161 02/15/22
Mazabraud Yann EVP, Head of Interna.. EVP, Head of International Feb 11 Sell 6.1 934 5,697 1,098 02/15/22
Chien Jennifer EVP, Head of North A.. EVP, Head of North America Feb 11 Sell 6.1 722 4,404 1,310 02/15/22